InMode Ltd. (INMD)

Name: InMode Ltd. (INMD) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: InMode Ltd. (INMD)

Stock Card

$14.85

$0.01 (0.07%)

As on 28-Aug-2026 16:00EDT

Market cap

$855 Mln

Revenue (TTM)

$375 Mln

P/E Ratio

12.3

P/B Ratio

1.4

Div. Yield

0 %

Value Research Rating

Quality Score

Growth Score

Valuation Score

Momentum Score

Know more

Explore 5 star rated stocks

InMode (INMD) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 14.83 High: 14.94

52 Week Range

Low: 12.72 High: 16.74

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

0.1 %
ROCE

-- %
Industry P/E

--
EV/EBITDA

5.1
Debt to Equity

0
Book Value

$10.7
EPS

$1.2
Face value

--
Shares outstanding

57,544,172

8 Years Aggregate

CFO

$729.21 Mln

EBITDA

$744.82 Mln

Net Profit

$692.11 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
InMode (INMD)	1.1	-3.4	7.5	-2.2	-26.9	-25.6	--
BSE Sensex^*	-9.0	-1.1	3.1	-3.4	5.8	6.3	10.5
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 28-Aug-2026 | *As on 31-Aug-2026 | #As on 26-Oct-2023

Company	2025	2023	2022	2021	2020
InMode (INMD)	-12.0	-37.7	-49.4	197.3	21.1
S&P Small-Cap 600	4.0	13.9	-17.4	25.3	9.6
BSE Sensex	9.1	18.7	4.4	22.0	15.8

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price ($)	Market Cap ($ Mln)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
InMode (INMD)	14.9	854.5	374.6	77.5	22.3	11.8	12.3	1.4
IceCure Medical (ICCM)	2.3	7.9	4.0	-16.9	-423.7	-161.2	--	0.7

Shareholding Pattern

View Details

About InMode (INMD)

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe,... Asia, and internationally. It offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. The company also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions. In addition, it offers hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company sells and markets its products in the United States, Canada, the United Kingdom, Ireland, Spain, Portugal, France, Belgium, Luxemburg, Italy, Germany, Austria, Japan, Australia, and India through distributors. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. The company was incorporated in 2008 and is headquartered in Yokne'am, Israel. Read more

Chief Financial Officer

Mr. Yair Malca
Chief Financial Officer

Mr. Yair Malca
Headquarters

Yokne'am
Website

https://www.inmodemd.com

FAQs for InMode (INMD)

What is the current share price of InMode Ltd (INMD) Today?

The share price of InMode Ltd (INMD) is $14.85 (NASDAQ) as of 28-Aug-2026 16:00 EDT. InMode Ltd (INMD) has given a return of -26.91% in the last 3 years.